Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infliximab”

421 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 421 results

Not applicableUnknownNCT02852850
What this trial is testing

In Vivo Molecular Imaging Predicts Therapeutic Response in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shandong University 30
Post-approval studies (Phase 4)Study completedNCT02453776
What this trial is testing

Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab

Who this might be right for
Inflammatory Bowel Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 80
Not applicableUnknownNCT04109300
What this trial is testing

Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Western University, Canada 162
Not applicableLooking for participantsNCT04331639
What this trial is testing

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Who this might be right for
Inflammatory Bowel DiseaseCrohn DiseaseUlcerative Colitis+1 more
Boston Children's Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00523354
What this trial is testing

Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis

Who this might be right for
Esophagitis
Swiss EE Study Group
Not applicableStudy completedNCT01233583
What this trial is testing

Regulatory T-cells in Psoriasis Patients as Targets for Therapy

Who this might be right for
Psoriasis
University of Aberdeen 38
Large-scale testing (Phase 3)Study completedNCT00269854
What this trial is testing

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

Who this might be right for
Crohn Disease
Centocor, Inc. 108
Not applicableLooking for participantsNCT07123207
What this trial is testing

Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Disease

Who this might be right for
Mild to Severe Crohns Disease
The Third Xiangya Hospital of Central South University 24
Not applicableStudy completedNCT02170714
What this trial is testing

Efficacy of Infliximab as a Rescue Therapy in Pediatric Acute Severe Colitis

Who this might be right for
Pediatric Acute Severe Colitis
University of Roma La Sapienza 31
Early research (Phase 1)Study completedNCT04779892
What this trial is testing

The Study of Infliximab (CMAB008 and Remicade) in Healthy Subjects to Compare the PK and Safety

Who this might be right for
Rheumatoid Arthritis
Taizhou Mabtech Pharmaceutical Co.,Ltd 90
Not applicableUnknownNCT01286545
What this trial is testing

European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study

Who this might be right for
Ankylosing Spondylitis
Rheumazentrum Ruhrgebiet 100
Testing effectiveness (Phase 2)Study completedNCT00006292
What this trial is testing

Infliximab for the Treatment of Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 60
Testing effectiveness (Phase 2)Study completedNCT00304954
What this trial is testing

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
National Eye Institute (NEI) 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Not applicableStudy completedNCT00741793
What this trial is testing

Biologic Treatment Registry Across Canada

Who this might be right for
Arthritis, RheumatoidSpondyloarthritis, AxialArthritis, Psoriatic
Janssen Inc. 2,821
Large-scale testing (Phase 3)Study completedNCT02222493
What this trial is testing

PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 650
Post-approval studies (Phase 4)Study completedNCT02425852
What this trial is testing

A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis

Who this might be right for
Ulcerative Colitis
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 65
Post-approval studies (Phase 4)Study completedNCT04775732
What this trial is testing

Ultra-proactive Therapeutic Drug Monitoring in Inflammatory Bowel Disease

Who this might be right for
Crohn DiseaseUlcerative Colitis
Imelda GI Clinical Research Center 187
Not applicableStudy completedNCT03074656
What this trial is testing

The Norwegian Drug Monitoring Study

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisAnkylosing Spondylitis+4 more
Diakonhjemmet Hospital 611
Load More Results